JPRN-jRCT2071220011已完成1 期
Clinical Pharmacology Study of NS-580 in Healthy female subjects (Phase I Study)
Higashioka Masaya0 个研究点目标入组 64 人开始时间: 2022年5月27日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 < 45age old（—）
- 性别
- Female
入选标准
- •1) Provided written informed consent
- •2) Japanese female subjects
- •3) Body mass index (BMI) >=17.6 and <25.0 kg/m2 at the time of screening tests and hospitalization
排除标准
- •1) Sublects who are pregnant, may become pregnant, or wish to become pregnant during the trial period
- •2) Subjects who are breastfeeding
- •3) Subjects who have not confirmed a regular menstrual cycle at the time of screening test
- •4) Subjects who are irregular bleeding
研究者
相似试验
已完成
1 期
Drug-drug interaction study of NS-580 in Healthy male subjects (Phase I Study)JPRN-jRCT2071220031Higashioka Masaya60
进行中（未招募）
2 期
A dose determination study of NS-580 in patients with endometriosis (late phase II)endometriosisJPRN-jRCT2031210685Higashioka Masaya372
已完成
2 期
An exploratory study of NS-580 in patients with endometriosis (early phase II)endometriosisJPRN-jRCT2080223592ippon Shinyaku Co., Ltd.150
招募中
1 期
A Phase I Clinical Study of NS-025 in Healthy SubjectsJPRN-jRCT2031220474Higashioka Masaya122
已完成
1 期
Clinical Pharmacology Study of NS-229 in Healthy male subjects (Phase I Study) (Drug-Drug Interaction Study with Prednisolone)JPRN-jRCT2051210094Higashioka Masaya20